As Ebola Outbreak Spreads in West Africa, U.S. Scientists Look for Cure

Just over a dozen American laboratories can experiment with the deadly virus, and one in Texas reports some promise in animal studies.

National Journal
Marina Koren
Add to Briefcase
Marina Koren
July 29, 2014, 11:15 a.m.

There’s a lot we don’t know about the Ebola vir­us.

The deadly vir­us likely comes from fruit bats, but sci­ent­ists don’t know for sure. They also don’t know all the ways the highly con­ta­gious vir­us is trans­mit­ted, nor how the dis­ease de­vel­ops with­in in­fec­ted people, al­most 90 per­cent of whom will die. And they don’t know to treat it or cure it.

Since Feb­ru­ary, the worst Ebola out­break West­ern Africa has ever seen has claimed more than 670 lives, in­clud­ing a prom­in­ent Liber­ia doc­tor who tried to con­tain the dis­ease. This month, the vir­us traveled by plane for the first time, when Patrick Saw­yer flew from Liber­ia to Ni­ger­ia, where he died days later from the vir­us.

As health work­ers try to con­tain the grow­ing out­break in Africa, sci­ent­ists 6,000 miles away are try­ing to de­vel­op the tools they need to do it.

Re­search­ers at the Galve­ston Na­tion­al Labor­at­ory in Texas are work­ing to pro­duce three prom­ising vac­cines and treat­ments for the Ebola vir­us, thanks to a $28 mil­lion grant from the Na­tion­al In­sti­tutes of Health. The labor­at­ory, op­er­ated by the Uni­versity of Texas Med­ic­al Branch, is one of only about 15 fa­cil­it­ies that are al­lowed to store and ex­per­i­ment with Ebola. The vir­us is clas­si­fied as a biosafety level 4 agent, the des­ig­na­tion giv­en by the Cen­ters for Dis­ease Con­trol and Pre­ven­tion to the most dan­ger­ous agents known to hu­mans. The Galve­ston labor­at­ory, and oth­er biosafety level 4 labs like it, is spe­cially equipped to handle — and con­tain — such agents.

The re­search­ers say they have had some suc­cess so far. “We have pre­vent­ive vac­cine and an­ti­vir­al drugs that can com­pletely pro­tect against Ebola on labor­at­ory an­im­als in a lab set­ting,” Thomas Geis­ber, a pro­fess­or of mi­cro­bi­o­logy and im­mun­o­logy at the Uni­versity of Texas Med­ic­al Branch, tells the loc­al ABC af­fil­i­ate. Geis­ber, like all re­search­ers and health work­ers who come in con­tact with the vir­us and in­fec­ted pa­tients, wears a pro­tect­ive body­suit every day while he works so he doesn’t con­tract Ebola him­self.

Ebola first ap­peared in 1976 in what is now known as the Demo­crat­ic Re­pub­lic of Congo. The vir­us at­tacks the im­mune sys­tem, caus­ing fever, vomit­ing, diarrhea and, in the most severe cases, in­tern­al and ex­tern­al bleed­ing. Ex­perts be­lieve the vir­us is trans­mit­ted through con­tact with in­fec­ted people’s bod­ily flu­ids. The most doc­tors can do is give pa­tients flu­ids, keep their blood pres­sure down, and hope for the best.

Like most re­search on the Ebola vir­us, the ex­per­i­ment­al treat­ments at Galve­ston have shown prom­ise only in an­im­als, and even those res­ults are far too pre­lim­in­ary. The Ebola vir­us is in­cred­ibly dif­fi­cult to study. It’s highly in­fec­tious, so it can only be stud­ied in high-tech fa­cil­it­ies like the one in Galve­ston, which means few­er re­search­ers are work­ing on de­vel­op­ing a cure. People in­fec­ted with the vir­us do not live long enough for doc­tors to ex­am­ine how the dis­ease pro­gresses, and giv­ing it to hu­man test sub­jects in the lab is not an op­tion.

Pre­vi­ous out­breaks have been con­trolled and even­tu­ally petered out, but this year’s is dif­fer­ent. Its rap­id growth, as well as Saw­yer’s death, have sparked fears that the vir­us could travel out­side of Africa, where the dis­ease has nev­er been re­por­ted in hu­mans. As NBC’s Mag­gie Fox put it, Ebola “is only a short plane ride from any city on Earth.”

What We're Following See More »
FBI To Investigate New Clinton Emails
29 minutes ago
TO AIR OCT. 31 & NOV. 1
Stein, Johnson to Participate in PBS Candidate Forum
51 minutes ago

It was announced on Friday that Gary Johnson and Jill Stein will participate in a candidate's forum, to be filmed live on Oct. 31 and air in two parts. The forum will air on PBS's Tavis Smiley. Additionally, there will be a 30 minute discussion available exclusively online with questions selected from social media.

Obama: Michelle Will Never Run for Office
2 hours ago
North Dakota Pipeline Protests Turn Violent
3 hours ago

The protest over the construction of the Dakota Access Pipeline turned violent overnight as the police and National Guard sought to remove the protesters, surrounding them with assault vehicles and officers in riot gear. The law enforcement officers used pepper spray and fired bean bags for more than six hours. In response, the protesters "lit debris on fire and threw Molotov cocktails in retreat." One woman pulled out a gun and fired at officers, narrowly missing before being arrested. The protesters claim the pipeline would be constructed on land belonging to the Standing Rock Sioux Tribe.

House Leadership Elections Slated for Nov. 15
4 hours ago

The House has scheduled leadership votes for Nov. 15, the day after members return from their election recess. "Since mid-September, members of the House Freedom Caucus have weighed whether they should ask leadership to push back the elections so they can see how House Speaker Paul Ryan performs at the end of the year," but leaders don't seem inclined to grant their request.


Welcome to National Journal!

You are currently accessing National Journal from IP access. Please login to access this feature. If you have any questions, please contact your Dedicated Advisor.